Clinical Trials on HER2 Amplified Solid Tumors in Belgium
Total 215 results
-
Novartis PharmaceuticalsNantCell, Inc.TerminatedPIK3CA Mutated Advanced Solid Tumors | PIK3CA Amplified Advanced Solid TumorsSpain, Belgium, United States, Canada
-
AstraZenecaDaiichi Sankyo Co., Ltd.RecruitingPart 1: Bladder, Biliary Tract, Cervical, Endometrial, Ovarian, Pancreatic Cancer, Rare Tumors, Any Tumor Type Excluding Breast, Gastric, Colorectal Cancer | Part 2: HER2 Expressing/Amplified Solid Tumors Excluding Breast, Gastric, Colorectal CancerCanada, Korea, Republic of, Taiwan, United States, Italy, United Kingdom, Thailand, Russian Federation, India, Belgium, Australia, Poland, Spain, Japan, Brazil, Czechia, Netherlands
-
Astellas Pharma Global Development, Inc.Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedAdvanced Breast Cancer | HER2 Amplified | Human Epidermal Growth Factor Receptor 2 (HER2)United States, Belgium, Canada, Italy, Spain, United Kingdom
-
Eli Lilly and CompanyActive, not recruitingPancreatic Cancer | Solid Tumor | Cutaneous Melanoma | Microsatellite Instability-High (MSI-H) Solid Tumors | Breast Cancer (HR+HER2-)Belgium, Spain, Korea, Republic of, United States, Taiwan, France, Canada
-
Puma Biotechnology, Inc.TerminatedSolid Tumors Harboring Somatic HER2 or EGFR Exon 18 MutationsFrance, United States, Spain, Belgium, United Kingdom, Serbia, Australia, Israel, Canada, Denmark, Ireland, Italy, Korea, Republic of
-
Oncoethix GmbHUnknown
-
Clavis PharmaCompletedSolid TumorsNetherlands, Belgium
-
Boehringer IngelheimRecruiting
-
Elro PharmaCompleted
-
PfizerCompletedSolid TumorsUnited States, Belgium
-
Eli Lilly and CompanyCompletedSolid TumorsUnited States, Spain, France, Belgium
-
Taiho Oncology, Inc.CompletedAdvanced Solid TumorsFrance, Belgium, Italy, Switzerland
-
Byondis B.V.CompletedSolid TumorFrance, Belgium
-
Universitair Ziekenhuis BrusselKom Op Tegen KankerRecruitingBreast Cancer | Melanoma (Skin) | Malignant Solid TumorBelgium
-
Hoffmann-La RocheTerminatedSolid TumorsSpain, Belgium, Denmark, Canada
-
AstraZenecaDaiichi Sankyo Co., Ltd.Active, not recruitingAdvanced Solid Tumors With HER2 Mutation,eg:Colorectal,Urothelial,Gastric, Hepatobiliary,Endometrial,Melanoma,Ovarian,Cervical,Salivary Gland,Pancreatic,BreastItaly, Spain, United States, France, Korea, Republic of, Japan, Canada, Denmark, Belgium
-
AstraZenecaMerck Sharp & Dohme LLC; Iqvia Pty LtdCompletedMalignant Solid TumorBelgium
-
iOmx Therapeutics AGRecruitingSolid TumorSpain, Belgium
-
iTeos TherapeuticsRecruitingSolid Tumor, AdultBelgium, United Kingdom
-
InteRNATerminatedSolid TumorNetherlands, Belgium
-
Merck KGaA, Darmstadt, GermanyMerck Serono S.A., GenevaCompletedCancer | Solid TumorsFrance, Belgium, Australia, Netherlands
-
Byondis B.V.Active, not recruitingSolid TumorBelgium, Italy, Netherlands, United Kingdom
-
AstraZenecaCompletedSolid TumoursNetherlands, Belgium
-
Exscientia AI LimitedBiotrialTerminatedAdvanced Solid TumoursFrance, Belgium
-
Brugmann University HospitalCompletedElderly Patients With a Solid TumorBelgium
-
Novartis PharmaceuticalsCompletedSolid TumorsNetherlands, Spain, United Kingdom, United States, Belgium
-
Hoffmann-La RocheTerminatedSolid TumorsBelgium, United States, Australia, Denmark, Spain, United Kingdom
-
Hoffmann-La RocheTerminatedSolid TumorsSpain, Australia, Belgium, Denmark, Canada
-
Hoffmann-La RocheActive, not recruitingSolid TumorsBelgium, Denmark, Spain, Canada, Netherlands, Poland
-
European Organisation for Research and Treatment...CompletedUnspecified Adult Solid Tumor, Protocol SpecificBelgium, Netherlands
-
AstraZenecaCompletedSolid TumoursBelgium, United Kingdom, Netherlands
-
MonTa Biosciences ApSAllucentRecruitingAdvanced Solid TumorBelgium, Denmark, Spain
-
Hoffmann-La RocheCompletedSolid TumorsUnited States, Spain, Belgium, Denmark, Canada, Australia
-
AstraZenecaActive, not recruitingSolid TumorsBelgium, United Kingdom, Switzerland, Australia
-
Byondis B.V.CompletedSolid TumorUnited Kingdom, Belgium, Netherlands
-
Boehringer IngelheimActive, not recruitingSolid Tumors, KRAS MutationSpain, United Kingdom, United States, Belgium
-
PharmaMarRecruitingAdvanced Solid TumorBelgium, United States, Spain
-
Kling Biotherapeutics B.V.RecruitingAdvanced Solid Tumor MalignancyBelgium, Netherlands
-
Lupin Ltd.CompletedA Study of LNP3794 in Subjects With NRAS/KRAS Mutated Advanced or Metastatic Refractory Solid TumorsNRAS/KRAS Mutated Advanced or Metastatic Refractory Solid TumorsUnited Kingdom, Netherlands, Belgium
-
SOTIO Biotech AGRecruitingAdvanced Solid Tumor | Metastatic Solid TumorUnited States, Spain, Czechia, Belgium, France
-
T-knife GmbHTerminatedAdvanced Solid TumorsGermany, Belgium, Spain, Netherlands, United Kingdom
-
amcure GmbHCompletedMalignant Solid TumorBelgium, Spain
-
Hoffmann-La RocheCompletedSolid TumorsHungary, United States, Korea, Republic of, Belgium, Germany, United Kingdom
-
Pyxis Oncology, IncRecruiting
-
Exscientia AI LimitedGT Apeiron LLCRecruitingAdvanced Solid TumorUnited Kingdom, Belgium
-
Novartis PharmaceuticalsCompletedSolid TumorsAustria, Belgium, United States, Italy, Denmark, Spain, Japan
-
AmgenCompletedAdvanced Solid TumorsUnited States, Belgium, Spain, Australia
-
Eli Lilly and CompanyActive, not recruitingRelapsed Solid Tumor | Refractory Solid TumorUnited States, Canada, France, Australia, Belgium, Germany, Spain, Italy
-
Centre Oscar LambretBristol-Myers Squibb; Anticancer Fund, Belgium; CTD-CNO; ECS-Progastrin SAActive, not recruitingChildhood Solid TumorFrance, Belgium
-
AstraZenecaCompletedSolid TumoursBelgium, Denmark, United Kingdom, Netherlands